000			02172nam a22003498i 4500
001			CR9780511544156
003			UkCbUP
005			20200124160244.0
006			m|||||o||d||||||||
007			cr||||||||||||
008			090506s2007||||enk o ||1 0|eng|d
020			_a9780511544156 (ebook)
020			_z9780521834919 (hardback)
020			_z9781107407411 (paperback)
040			_aUkCbUP _beng _erda _cUkCbUP
050	0	0	_aQP572.N6 _bB73 2007
082	0	0	_a612.8042 _222
245	0	0	_aBrain norepinephrine : _bneurobiology and therapeutics / _cedited by Gregory A. Ordway, Michael A. Schwartz, Alan Frazer.
264		1	_aCambridge : _bCambridge University Press, _c2007.
300			_a1 online resource (xiv, 642 pages) : _bdigital, PDF file(s).
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
500			_aTitle from publisher's bibliographic system (viewed on 05 Oct 2015).
520			_aThis book was first published in 2007. Norepinephrine is a chemical neurotransmitter. Drugs that directly manipulate central nervous system (CNS) norepinephrine are being developed targeting noradrenergic neurons to deliver therapeutic effects. Noradrenergic drugs have been proven effective for depression and ADHD, and new disease indications are being identified. A team of experts provides the reader with a thorough understanding of the anatomy, physiology, molecular biology, pharmacology and therapeutics of norepinephrine in the brain, including an extensive review of the role of norepinephrine in brain diseases. The book is divided into four sections: the basic biology of norepinephrine; the role that norepinephrine plays in behavior; evidence of norepinephrine's role in CNS diseases, and the pharmacology and therapeutics of noradrenergic drugs in the treatment of psychiatric and neurological disorders.
650		0	_aNoradrenaline.
700	1		_aOrdway, Gregory A, _eeditor.
700	1		_aSchwartz, Michael A. _q(Michael Alan), _eeditor.
700	1		_aFrazer, Alan, _eeditor.
776	0	8	_iPrint version: _z9780521834919
856	4	0	_uhttps://doi.org/10.1017/CBO9780511544156
999			_c518805 _d518803